These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


174 related items for PubMed ID: 24123353

  • 1. A selective sigma-2 receptor ligand antagonizes cocaine-induced hyperlocomotion in mice.
    Lever JR, Miller DK, Green CL, Fergason-Cantrell EA, Watkinson LD, Carmack TL, Fan KH, Lever SZ.
    Synapse; 2014 Feb; 68(2):73-84. PubMed ID: 24123353
    [Abstract] [Full Text] [Related]

  • 2. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418.
    Lever JR, Miller DK, Fergason-Cantrell EA, Green CL, Watkinson LD, Carmack TL, Lever SZ.
    J Pharmacol Exp Ther; 2014 Oct; 351(1):153-63. PubMed ID: 25100754
    [Abstract] [Full Text] [Related]

  • 3. Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.
    Lever JR, Fergason-Cantrell EA, Watkinson LD, Carmack TL, Lord SA, Xu R, Miller DK, Lever SZ.
    Synapse; 2016 Mar; 70(3):98-111. PubMed ID: 26618331
    [Abstract] [Full Text] [Related]

  • 4. Effect of structural modification in the amine portion of substituted aminobutyl-benzamides as ligands for binding σ1 and σ2 receptors.
    Fan KH, Lever JR, Lever SZ.
    Bioorg Med Chem; 2011 Mar 15; 19(6):1852-9. PubMed ID: 21376604
    [Abstract] [Full Text] [Related]

  • 5. Conformationally restricted analogs of BD1008 and an antisense oligodeoxynucleotide targeting sigma1 receptors produce anti-cocaine effects in mice.
    Matsumoto RR, McCracken KA, Friedman MJ, Pouw B, De Costa BR, Bowen WD.
    Eur J Pharmacol; 2001 May 11; 419(2-3):163-74. PubMed ID: 11426838
    [Abstract] [Full Text] [Related]

  • 6. Electron-donating para-methoxy converts a benzamide-isoquinoline derivative into a highly Sigma-2 receptor selective ligand.
    Hajipour AR, Guo LW, Pal A, Mavlyutov T, Ruoho AE.
    Bioorg Med Chem; 2011 Dec 15; 19(24):7435-40. PubMed ID: 22055714
    [Abstract] [Full Text] [Related]

  • 7. Novel sigma receptor ligands attenuate the locomotor stimulatory effects of cocaine.
    McCracken KA, Bowen WD, Matsumoto RR.
    Eur J Pharmacol; 1999 Jan 15; 365(1):35-8. PubMed ID: 9988120
    [Abstract] [Full Text] [Related]

  • 8. Sigma2 (sigma2) receptors as a target for cocaine action in the rat striatum.
    Nuwayhid SJ, Werling LL.
    Eur J Pharmacol; 2006 Mar 27; 535(1-3):98-103. PubMed ID: 16480713
    [Abstract] [Full Text] [Related]

  • 9. Trishomocubanes: novel sigma ligands modulate cocaine-induced behavioural effects.
    Liu X, Banister SD, Christie MJ, Banati R, Meikle S, Coster MJ, Kassiou M.
    Eur J Pharmacol; 2007 Jan 19; 555(1):37-42. PubMed ID: 17113074
    [Abstract] [Full Text] [Related]

  • 10. Serotonin transporter inhibition and 5-HT2C receptor activation drive loss of cocaine-induced locomotor activation in DAT Val559 mice.
    Stewart A, Davis GL, Gresch PJ, Katamish RM, Peart R, Rabil MJ, Gowrishankar R, Carroll FI, Hahn MK, Blakely RD.
    Neuropsychopharmacology; 2019 Apr 19; 44(5):994-1006. PubMed ID: 30578419
    [Abstract] [Full Text] [Related]

  • 11. Structure-activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl)propyl]carbazole (rimcazole) analogues.
    Husbands SM, Izenwasser S, Kopajtic T, Bowen WD, Vilner BJ, Katz JL, Newman AH.
    J Med Chem; 1999 Oct 21; 42(21):4446-55. PubMed ID: 10543888
    [Abstract] [Full Text] [Related]

  • 12. Trishomocubane as a scaffold for the development of selective dopamine transporter (DAT) ligands.
    Banister SD, Moussa IA, Beinat C, Reynolds AJ, Schiavini P, Jorgensen WT, Kassiou M.
    Bioorg Med Chem Lett; 2011 Jan 01; 21(1):38-41. PubMed ID: 21146989
    [Abstract] [Full Text] [Related]

  • 13. Conformationally-flexible benzamide analogues as dopamine D3 and sigma 2 receptor ligands.
    Mach RH, Huang Y, Freeman RA, Wu L, Vangveravong S, Luedtke RR.
    Bioorg Med Chem Lett; 2004 Jan 05; 14(1):195-202. PubMed ID: 14684327
    [Abstract] [Full Text] [Related]

  • 14. Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.
    Matsumoto RR, Pouw B, Mack AL, Daniels A, Coop A.
    Pharmacol Biochem Behav; 2007 Jan 05; 86(1):86-91. PubMed ID: 17241657
    [Abstract] [Full Text] [Related]

  • 15. Modulation of amphetamine-stimulated (transporter mediated) dopamine release in vitro by sigma2 receptor agonists and antagonists.
    Izenwasser S, Thompson-Montgomery D, Deben SE, Chowdhury IN, Werling LL.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):189-96. PubMed ID: 9652359
    [Abstract] [Full Text] [Related]

  • 16. Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.
    Motel WC, Healy JR, Viard E, Pouw B, Martin K, Matsumoto RR, Coop A.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6920-6922. PubMed ID: 24211020
    [Abstract] [Full Text] [Related]

  • 17. Effect of sigma ligands on the cocaine-induced convulsions in mice.
    Skuza G.
    Pol J Pharmacol; 1999 Dec 15; 51(6):477-83. PubMed ID: 10817525
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and quantitative structure-activity relationships of N-(1-benzylpiperidin-4-yl)phenylacetamides and related analogues as potent and selective sigma1 receptor ligands.
    Huang Y, Hammond PS, Whirrett BR, Kuhner RJ, Wu L, Childers SR, Mach RH.
    J Med Chem; 1998 Jun 18; 41(13):2361-70. PubMed ID: 9632369
    [Abstract] [Full Text] [Related]

  • 19. Dual probes for the dopamine transporter and sigma1 receptors: novel piperazinyl alkyl-bis(4'-fluorophenyl)amine analogues as potential cocaine-abuse therapeutic agents.
    Cao J, Kulkarni SS, Husbands SM, Bowen WD, Williams W, Kopajtic T, Katz JL, George C, Newman AH.
    J Med Chem; 2003 Jun 19; 46(13):2589-98. PubMed ID: 12801223
    [Abstract] [Full Text] [Related]

  • 20. Effects of N-phenylpropyl-N'-substituted piperazine sigma receptor ligands on cocaine-induced hyperactivity in mice.
    Sage AS, Oelrichs CE, Davis DC, Fan KH, Nahas RI, Lever SZ, Lever JR, Miller DK.
    Pharmacol Biochem Behav; 2013 Sep 19; 110():201-7. PubMed ID: 23891829
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.